Stories from people navigating Obesity — diagnosis, treatment, caregiving, and the ordinary days in between.
18 stories
Endocrinology & Metabolism
Alcohol Use Disorder (AUD) represents one of the most persistent public health crises in modern medicine, driving severe
Rayan Salih · August 5, 2026 · 9 min
Oncology
The metabolic landscape of oncology is rapidly evolving, driven by an expanding understanding of how systemic metabolic dysfunction
Rayan Salih · 8 min read
Endocrinology & Metabolism
The rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has fundamentally transformed the management of type 2
Rayan Salih · 8 min read
Cardiology
GLP-1 agonist drugs (like semaglutide or liraglutide) have become common choices for treating obesity and type 2 diabetes….
Dr. Abu Bakar · 7 min read
Endocrinology & Metabolism
The biopharmaceutical industry is undergoing a structural realignment that will directly shape clinical practice, formulary designs, and treatment
Rayan Salih · 7 min read
Mental & Behavioral Health
The GLP-1 receptor agonist is an agent used for the management of type 2 diabetes mellitus and body
Dr. Abu Bakar · 7 min read
Endocrinology & Metabolism
The Trump administration has formally announced a delay of the Medicare Part D implementation of the Center for
Rayan Salih · 13 min read
Neurology
Research to treat Alzheimer’s and other neurodegenerative diseases has been largely focused on removal of amyloid-beta plaques and
Rayan Salih · 10 min read
Endocrinology & Metabolism
Background: Central obesity is an emerging public health concern in Botswana with high prevalence among adults.
Dr. Abu Bakar · 12 min read
Cardiology
There is an ever increasing epidemic of obesity amongst African American women, already disproportionately affected by high rates
Dr. Abu Bakar · 12 min read
Endocrinology & Metabolism
As obesity medications become a routine component of clinical practice, individualized therapy has emerged as the central guiding
Rayan Salih · 7 min read
Endocrinology & Metabolism
There has been a “miracle drug” renaissance in recent years with a new generation of weight loss and
Dr. Abu Bakar · 15 min read
Endocrinology & Metabolism
The US Food and Drug Administration (FDA) completed labeling updates for Eli Lilly’s Zepbound (tirzepatide), a first-in-class combination
Rayan Salih · 4 min read
Cardiology
Due to the current benefit design, patients with obesity, diabetes and other related conditions are experiencing avoidable harm
Dr. Abu Bakar · 16 min read
Innovation & Devices
Incretin agonists, including the GLP-1 receptor agonists and the dual incretin tirzepatide, are redefining our understanding of obstructive
Dr. Abu Bakar · 11 min read
Endocrinology & Metabolism
With MHT again in the headlines on both benefits and risks for women, we’ll review the basics and
Rayan Salih · 3 min read
Endocrinology & Metabolism
Gut Linco Peptide-1 (GLP-1) medications have found a new “lease of life” as potential weight loss treatments.
Dr. Abu Bakar · 9 min read
Endocrinology & Metabolism
In recent years, several new medications for obesity and diabetes have entered the market, promising significant health benefits….
Rayan Salih · 8 min read
Other conditions
One story a day
One health journey each morning — no advice, no alarm, just company for the road.